|
1
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOCAN 2012 v1.1. Cancer Incidence and Mortality
Worldwide: IARC CancerBase No. 11 (Internet). Lyon, France:
International Agency for Research on Cancer. 2014.http://globocan.iarc.frAccessed. Jan 16–2015
|
|
2
|
Saudi Cancer Registry: Cancer Incidence
Report Saudi Arabia 2005. Kingdom of Saudi Arabia, Ministry of
Health, Saudi Cancer Registry. http://www.scr.org.sa/reports/SCR2005.pdfAccessed.
Oct 12–2015
|
|
3
|
Mosli MH and Al-Ahwal MS: Colorectal
cancer in the Kingdom of Saudi Arabia: need for screening. Asian
Pac J Cancer Prev. 13:3809–3813. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ibrahim EM, Zeeneldin AA, El-Khodary TR,
Al-Gahmi AM and Sadiq Bin BM: Past, present and future of
colorectal cancer in the Kingdom of Saudi Arabia. Saudi J
Gastroenterol. 14:178–182. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
O'Connell JB, Maggard MA and Ko CY: Colon
cancer survival rates with the new American Joint Committee on
Cancer sixth edition staging. J Natl Cancer Inst. 96:1420–1425.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levin B, Lieberman DA, McFarland B, Smith
RA, Brooks D, Andrews KS, Dash C, Giardiello FM, Glick S, Levin TR,
et al: American Cancer Society Colorectal Cancer Advisory Group; US
Multi-Society Task Force; American College of Radiology Colon
Cancer Committee: Screening and surveillance for the early
detection of colorectal cancer and adenomatous polyps, 2008: a
joint guideline from the American Cancer Society, the US
Multi-Society Task Force on Colorectal Cancer, and the American
College of Radiology. CA Cancer J Clin. 58:130–160. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mandel JS: Screening for colorectal
cancer. Gastroenterol Clin North Am. 3797–115. (vii)2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Herranz H and Cohen SM: MicroRNAs and gene
regulatory networks: managing the impact of noise in biological
systems. Genes Dev. 24:1339–1344. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hannafon BN, Sebastiani P, de las Morenas
A, Lu J and Rosenberg P: Expression of microRNA and their gene
targets are dysregulated in preinvasive breast cancer. Breast
Cancer Res. 13:R242011. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Miko E, Czimmerer Z, Csánky E, Boros G,
Buslig J, Dezso B and Scholtz B: Differentially expressed microRNAs
in small cell lung cancer. Exp Lung Res. 35:646–664. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Akao Y, Nakagawa Y and Naoe T:
MicroRNA-143 and −145 in colon cancer. DNA Cell Biol. 26:311–320.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bandrés E, Cubedo E, Agirre X, Malumbres
R, Zárate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzó M, et
al: Identification by Real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:29–38. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James P: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
15
|
Peng J, Xie Z, Cheng L, Zhang Y, Chen J,
Yu H, Li Z and Kang H: Paired design study by real-time PCR:
miR-378* and miR-145 are potent early diagnostic biomarkers of
human colorectal cancer. BMC Cancer. 15:158–165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schepeler T, Reinert JT, Ostenfeld MS,
Christensen LL, Silahtaroglu AN, Dyrskjøt L, Wiuf C, Sørensen FJ,
Kruhøffer M, Laurberg S, et al: Diagnostic and prognostic microRNAs
in stage II colon cancer. Cancer Res. 68:6416–6424. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et
al: MicroRNA expression profiles associated with prognosis and
therapeutic outcome in colon adenocarcinoma. JAMA. 299:425–436.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Waldman SA and Terzic A: MicroRNA
signatures as diagnostic and therapeutic targets. Clin Chem.
54:943–944. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsang JC and Lo YM: Circulating nucleic
acids in plasma/serum. Pathology. 39:197–207. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: a novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang Z, Huang D, Ni S, Peng Z, Sheng W
and Du X: Plasma microRNAs are promising novel biomarkers for early
detection of colorectal cancer. Int J Cancer. 127:118–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The microRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu L, Chen L, Xu Y, Li R and Du X:
microRNA-195 promotes apoptosis and suppresses tumorigenicity of
human colorectal cancer cells. Biochem Biophys Res Commun.
400:236–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li X, Wang Q, Zheng Y, Lv S, Ning S, Sun
J, Huang T, Zheng Q, Ren H, Xu J, et al: Prioritizing human cancer
microRNAs based on genes' functional consistency between microRNA
and cancer. Nucleic Acids Res. 39:e1532011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cui SY, Wang R and Chen LB: MicroRNA-145:
A potent tumour suppressor that regulates multiple cellular
pathways. J Cell Mol Med. 18:1913–1926. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hou Y, Wang X, Chen Y and Mu S:
MicroRNA-145 as an ideal biomaker for the diagnosis of various
carcinomas. Tumour Biol. 36:2641–2649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
UICC: TNM Classification of Malignant
Tumours. Sobin LH and Wittekind Ch: (6th). Hoboken, NJ: John Wiley
& Sons. 2002.
|
|
30
|
Duttagupta R, Jiang R, Gollub J, Getts RC
and Jones KW: Impact of cellular miRNAs on circulating miRNA
biomarker signatures. PLoS One. 6:e207692011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kirschner MB, Kao SC, Edelman JJ,
Armstrong NJ, Vallely MP, van Zandwijk N and Reid G: Haemolysis
during sample preparation alters microRNA content of plasma. PLoS
One. 6:e241452011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Allawi HT, Dahlberg JE, Olson S, Lund E,
Olson M, Ma WP, Takova T, Neri BP and Lyamichev VI: Quantitation of
microRNAs using a modified Invader assay. RNA. 10:1153–1161. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu CG, Calin GA, Meloon B, Gamliel N,
Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, et
al: An oligonucleotide microchip for genome-wide microRNA profiling
in human and mouse tissues. Proc Natl Acad Sci USA. 101:9740–9744.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Andrews WJ, Brown ED, Dellett M, Hogg RE
and Simpson DA: Rapid quantification of microRNAs in plasma using a
fast real-time PCR system. Biotechniques. 58:244–252.
2015.PubMed/NCBI
|
|
37
|
Zubakov D, Boersma AW, Choi Y, van Kuijk
PF, Wiemer EA and Kayser P: MicroRNA markers for forensic body
fluid identification obtained from microarray screening and
quantitative RT-PCR confirmation. Int J Legal Med. 124:217–226.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Etheridge A, Lee I, Hood L, Galas D and
Wang K: Extracellular microRNA: a new source of biomarkers. Mutat
Res. 717:85–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Luo X, Stock C, Burwinkel B and Brenner H:
Identification and evaluation of plasma microRNAs for early
detection of colorectal cancer. PLoS One. 8:e628802013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Song J, Bai Z, Han W, Zhang J, Meng H, Bi
J, Ma X, Han S and Zhang Z: Identification of suitable reference
genes for qPCR analysis of serum microRNA in gastric cancer
patients. Dig Dis Sci. 57:897–904. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Fang C, Zhu DX, Dong HJ, Zhou ZJ, Wang YH,
Liu L, Fan L, Miao KR, Liu P, Xu W, et al: Serum microRNAs are
promising novel biomarkers for diffuse large B cell lymphoma. Ann
Hematol. 91:553–559. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Watahiki A and Wang Y, Morris J, Dennis K,
O'Dwyer HM, Gleave M, Gout PW and Wang Y: MicroRNAs associated with
metastatic prostate cancer. PLoS One. 6:e249502011. View Article : Google Scholar : PubMed/NCBI
|
